— Know what they know.
Not Investment Advice

AHCO NASDAQ

AdaptHealth Corp.
1W: -4.1% 1M: +3.5% 3M: -45.8% YTD: -39.5% 1Y: -37.6% 3Y: -23.4% 5Y: -76.8%
$5.85
-0.08 (-1.35%)
 
Weekly Expected Move ±5.1%
$5 $6 $6 $6 $7
NASDAQ · Healthcare · Medical - Devices · Tech Score Neutral · Power 53 · $797.6M mcap · 86M float · 3.02% daily turnover · Short 45% of daily vol
Credit Risk of going bust: higher than 89% of companies Debt: 72.1% of company value Bonds: $144.5M held by 155 funds, 185 bp over Treasuries → details ▾
Of US companies ranked in the second-riskiest tenth, about 1 in 87 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.04 (down 82%), AdaptHealth Corp. would be worth roughly what it owes.
Total debt $2.07B against a stock market value of $797.6M.
Distance to default 1.75 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $948.0M (short-term plus half of long-term), stock volatility 68.6%; Altman Z 0.57. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
34.0 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -0.2%  ·  5Y Avg: -2.8%
Cost Advantage ★
57
Intangibles
36
Switching Cost
17
Network Effect
27
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. AHCO has No discernible competitive edge (34.0/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. Negative ROIC of -0.2% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$8
Low
$9
Avg Target
$10
High
Based on 6 analysts since Aug 4, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 9Hold: 2Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$9.33
Analysts6
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-17 Robert W. Baird — $10 $9 -1 +52.3% $5.91
2026-08-06 UBS Kevin Caliendo $13 $10 -3 +54.0% $6.50
2026-08-06 RBC Capital — $15 $8 -7 +23.2% $6.50
2026-08-05 Truist Financial — $12 $9 -3 +38.4% $6.50
2026-08-05 Robert W. Baird Eric Coldwell $15 $10 -5 +49.0% $6.71
2026-08-05 Canaccord Genuity — $16 $10 -6 +49.0% $6.71
2026-07-21 Jefferies Brian Tanquilut $11 $13 +2 +18.4% $10.98
2026-07-06 Robert W. Baird — $18 $15 -3 +39.4% $10.76
2026-05-11 RBC Capital — $13 $15 +2 +30.2% $11.53
2026-05-06 Canaccord Genuity — Initiated $16 — +36.2% $11.75
2026-05-06 Robert W. Baird Eric Coldwell $14 $18 +4 +53.2% $11.75
2026-04-20 Jefferies Brian Tanquilut Initiated $11 — -13.6% $12.73
2026-02-26 Leerink Partners Whit Mayo $29 $12 -17 +28.6% $9.33
2026-02-25 RBC Capital Ben Hendrix $29 $13 -16 +45.9% $8.91
2024-11-15 Truist Financial David MacDonald $28 $12 -16 +22.4% $9.80
2024-11-06 Robert W. Baird Eric Coldwell $16 $14 -2 +54.4% $9.07
2024-09-23 Robert W. Baird Eric Coldwell Initiated $16 — +40.1% $11.42
2024-08-08 UBS Kevin Caliendo Initiated $13 — +36.4% $9.53
2022-09-20 Deutsche Bank — Initiated $28 — +28.4% $21.81
2022-09-19 Truist Financial — $24 $28 +4 +33.5% $20.98
2022-08-10 RBC Capital — Initiated $29 — +30.4% $22.24
2022-08-10 Leerink Partners — Initiated $29 — +30.4% $22.24
2022-07-26 Truist Financial David MacDonald Initiated $24 — +14.3% $21.00

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
Oct 27, 2026
DCF
5
ROE
1
ROA
1
D/E
1
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. AHCO receives an overall rating of C+. Strongest factors: DCF (5/5), P/B (4/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-08-05 B- C+
2026-08-04 C+ B-
2026-05-11 B- C+
2026-05-05 C+ B-
2026-03-02 B- C+
2026-02-24 B+ B-
2026-01-12 A- B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 19 Grade D
Profitability
4
Balance Sheet
22
Earnings Quality
33
Growth
51
Value
41
Momentum
49
Safety
15
Cash Flow
18
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. AHCO scores highest in Growth (51/100) and lowest in Profitability (4/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.69
Distress Zone
Piotroski F-Score
6/9
✗ ✓ ✗ ✓ ✗ ✓ ✓ ✓ ✓
Beneish M-Score
-4.20
Unlikely Manipulator
Ohlson O-Score
-5.92
Bankruptcy prob: 0.3%
Low Risk
Credit Rating
CCC
Score: 19.6/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: -2.53x
Accruals: -18.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. AHCO scores 0.69, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. AHCO scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. AHCO's score of -4.20 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. AHCO's implied 0.3% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. AHCO receives an estimated rating of CCC (score: 19.6/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-3.48x
PEG
0.11x
P/S
0.27x
P/B
0.58x
P/FCF
14.52x
P/OCF
2.43x
EV/EBITDA
11.41x
EV/Revenue
1.07x
EV/EBIT
-24.09x
EV/FCF
35.22x
Earnings Yield
-16.24%
FCF Yield
6.89%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. AHCO currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.932
NI / EBT
×
Interest Burden
1.730
EBT / EBIT
×
EBIT Margin
-0.044
EBIT / Rev
×
Asset Turnover
0.742
Rev / Assets
×
Equity Multiplier
2.931
Assets / Equity
=
ROE
-15.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. AHCO's ROE of -15.5% is driven by Asset Turnover (0.742), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.93 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$5.85
Median 1Y
$4.49
5th Pctile
$1.65
95th Pctile
$12.18
Ann. Volatility
61.3%
Analyst Target
$9.33
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Suzanne Foster
Chief Executive Officer
$1,000,000 $7,530,880 $10,256,240
Jason Clemens Financial
ancial Officer
$670,000 $3,496,474 $4,955,858
Toby Scott Barnhart
Chief Operating Officer
$600,000 $1,748,251 $3,046,114
Russell Schuster Commercial
ercial Officer
$450,000 $1,892,262 $2,973,728
Albert Prast Technology
nology Officer
$450,000 $1,748,251 $2,722,867

CEO Pay Ratio

292:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $10,256,240
Avg Employee Cost (SGA/emp): $35,073
Employees: 10,900

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
10,900
+3.8% YoY
Revenue / Employee
$297,693
Rev: $3,244,857,000
Profit / Employee
$-6,495
NI: $-70,794,000
SGA / Employee
$35,073
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 5.5% 12.9% 10.3% 6.8% 4.6% 3.3% 2.0% 2.0% -22.0% -37.6% -38.5% -37.7% -13.2% 6.0% 5.6% 5.2% 5.1% -4.7% -5.3% -15.5% -15.53%
ROA 2.0% 4.4% 4.2% 2.8% 1.8% 1.3% 0.8% 0.8% -8.6% -14.0% -14.2% -14.2% -4.7% 2.0% 1.9% 1.8% 1.8% -1.7% -1.8% -5.3% -5.30%
ROIC 4.2% 4.4% 5.0% 4.6% 4.1% 3.2% 2.7% 2.8% -7.0% -12.9% -12.2% -12.5% -1.1% 5.1% 4.7% 4.3% 4.4% 5.3% 4.7% -0.2% -0.25%
ROCE 3.5% 6.0% 7.2% 5.8% 4.9% 4.4% 3.8% 3.9% -7.5% -14.9% -15.0% -15.2% -1.9% 6.7% 6.4% 7.1% 7.1% 2.5% 2.0% -3.9% -3.93%
Gross Margin -12.1% 15.7% -13.8% -14.8% -16.0% 48.5% 12.0% -15.4% -18.8% 52.7% -6.9% -7.0% -14.1% 38.3% -13.3% -9.1% 18.5% 19.2% 12.4% 14.1% 14.08%
Operating Margin 16.0% 9.8% 9.8% 11.1% 9.5% 2.0% 3.5% 9.3% -79.0% -14.7% 8.5% 8.7% 10.6% 11.4% 4.0% 13.4% 8.0% 6.4% 0.8% -18.6% -18.61%
Net Margin 12.3% 3.3% 8.0% 2.6% 2.9% -0.2% 2.1% 2.4% -77.8% -17.2% -0.4% 3.3% 3.8% 5.9% -1.2% 2.5% 2.7% -12.1% -2.0% -18.1% -18.09%
EBITDA Margin 34.8% 19.4% 28.5% 24.3% 25.8% 10.0% 20.1% 26.1% -61.3% -9.9% 22.0% 25.5% 25.8% 22.3% 20.2% 29.0% 20.8% 2.8% 15.0% -2.2% -2.19%
FCF Margin 3.6% 3.2% 3.4% 0.9% 2.8% -0.6% 1.4% 0.7% 0.9% 4.2% 1.6% 5.1% 7.0% 8.9% 10.4% 8.8% 7.5% 7.7% 6.2% 3.0% 3.03%
OCF Margin 11.7% 12.1% 14.0% 13.4% 16.3% 12.6% 14.0% 13.3% 12.9% 14.2% 12.0% 15.4% 16.8% 20.5% 22.4% 21.0% 20.0% 21.2% 19.5% 18.1% 18.08%
ROE 3Y Avg snapshot only -19.38%
ROE 5Y Avg snapshot only -9.95%
ROA 3Y Avg snapshot only -6.26%
ROIC 3Y Avg snapshot only -4.93%
ROIC Economic snapshot only -0.25%
Cash ROA snapshot only 13.44%
Cash ROIC snapshot only 17.15%
CROIC snapshot only 2.87%
NOPAT Margin snapshot only -0.26%
Pretax Margin snapshot only -7.66%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 11.96%
SBC / Revenue snapshot only 0.53%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 48.51 21.36 11.00 18.07 27.24 37.19 39.06 38.36 -2.88 -1.43 -2.20 -1.97 -7.15 14.37 17.12 16.04 15.32 -18.52 -20.23 -6.16 -3.482
P/S Ratio 1.70 1.47 0.96 1.11 1.12 0.87 0.53 0.51 0.38 0.29 0.47 0.42 0.47 0.49 0.56 0.49 0.43 0.48 0.54 0.44 0.265
P/B Ratio 1.64 1.62 1.05 1.16 1.20 1.20 0.78 0.76 0.71 0.66 1.05 0.92 1.01 0.83 0.93 0.81 0.76 0.89 1.10 1.03 0.578
P/FCF 47.72 46.09 28.15 125.30 39.30 -146.85 38.16 76.41 40.15 6.77 28.75 8.18 6.69 5.51 5.32 5.59 5.76 6.15 8.61 14.52 14.521
P/OCF 14.52 12.10 6.86 8.30 6.84 6.90 3.78 3.85 2.91 2.02 3.93 2.71 2.80 2.40 2.48 2.34 2.16 2.24 2.75 2.43 2.432
EV/EBITDA 14.38 10.21 7.07 8.10 8.59 8.70 7.04 6.75 43.40 -15.79 -17.21 -15.93 12.40 5.29 5.71 5.00 4.69 6.50 7.37 11.41 11.410
EV/Revenue 2.77 2.44 1.92 2.10 2.07 1.64 1.23 1.21 1.06 0.94 1.17 1.08 1.11 1.26 1.34 1.21 1.07 1.11 1.17 1.07 1.066
EV/EBIT 32.38 19.42 13.03 17.00 20.62 23.45 21.65 21.23 -10.80 -5.37 -6.30 -5.92 -47.55 12.64 14.16 11.92 11.53 34.72 49.44 -24.09 -24.088
EV/FCF 77.57 76.78 56.48 237.89 73.02 -276.87 88.80 180.95 113.59 22.26 71.32 21.17 15.75 14.08 12.79 13.73 14.32 14.34 18.78 35.22 35.219
Earnings Yield 2.1% 4.7% 9.1% 5.5% 3.7% 2.7% 2.6% 2.6% -34.8% -70.0% -45.5% -50.8% -14.0% 7.0% 5.8% 6.2% 6.5% -5.4% -4.9% -16.2% -16.24%
FCF Yield 2.1% 2.2% 3.6% 0.8% 2.5% -0.7% 2.6% 1.3% 2.5% 14.8% 3.5% 12.2% 15.0% 18.1% 18.8% 17.9% 17.4% 16.3% 11.6% 6.9% 6.89%
PEG Ratio snapshot only 0.114
EV/OCF snapshot only 5.898
EV/Gross Profit snapshot only 6.620
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.64 1.34 1.39 1.39 1.35 1.28 1.23 1.24 1.31 1.21 1.33 1.15 1.24 1.33 1.29 1.06 1.08 1.02 0.92 1.12 1.124
Quick Ratio 1.44 1.09 1.16 1.15 1.08 1.00 0.97 0.99 1.05 1.00 1.11 0.94 1.00 1.09 1.07 0.82 0.86 0.81 0.71 0.98 0.976
Debt/Equity 1.20 1.15 1.11 1.10 1.08 1.08 1.09 1.06 1.33 1.57 1.60 1.50 1.44 1.36 1.34 1.23 1.18 1.25 1.33 1.50 1.498
Net Debt/Equity 1.03 1.08 1.06 1.04 1.03 1.06 1.04 1.04 1.30 1.52 1.55 1.45 1.37 1.29 1.31 1.19 1.13 1.18 1.30 1.47 1.467
Debt/Assets 0.46 0.45 0.45 0.45 0.44 0.45 0.44 0.44 0.49 0.51 0.52 0.49 0.49 0.47 0.47 0.45 0.43 0.44 0.45 0.48 0.476
Debt/EBITDA 6.45 4.36 3.74 4.04 4.16 4.17 4.20 3.98 28.76 -11.37 -10.63 -10.09 7.48 3.39 3.42 3.07 2.92 3.93 4.09 6.85 6.849
Net Debt/EBITDA 5.53 4.08 3.55 3.83 3.97 4.09 4.02 3.90 28.06 -10.99 -10.27 -9.77 7.14 3.22 3.33 2.97 2.80 3.71 3.99 6.71 6.706
Interest Coverage 1.97 3.01 3.50 2.75 2.23 1.89 1.56 1.50 -2.53 -4.55 -4.61 -4.53 -0.58 2.07 2.02 2.27 2.38 0.86 0.71 -1.41 -1.405
Equity Multiplier 2.61 2.55 2.46 2.44 2.43 2.43 2.45 2.39 2.73 3.09 3.08 3.04 2.95 2.86 2.83 2.74 2.71 2.84 2.94 3.15 3.149
Cash Ratio snapshot only 0.061
Debt Service Coverage snapshot only 2.967
Cash to Debt snapshot only 0.021
FCF to Debt snapshot only 0.047
Defensive Interval snapshot only 298.5 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.57 0.64 0.48 0.45 0.44 0.57 0.61 0.62 0.66 0.70 0.66 0.67 0.71 0.59 0.59 0.59 0.64 0.64 0.69 0.74 0.742
Inventory Turnover 23.38 22.09 25.23 25.29 21.71 20.36 22.16 24.59 22.52 22.54 22.08 22.31 21.23 19.59 21.06 18.43 17.70 18.25 18.83 21.29 21.287
Receivables Turnover 7.76 8.57 7.35 6.79 6.56 8.26 8.82 9.00 8.97 9.06 8.27 8.10 8.46 6.63 6.20 6.32 7.00 7.29 7.60 8.23 8.232
Payables Turnover 9.61 9.15 10.00 10.15 10.88 10.85 10.14 12.59 12.28 12.54 10.22 10.53 11.25 10.01 9.62 8.12 8.23 8.34 7.48 7.42 7.425
DSO 47 43 50 54 56 44 41 41 41 40 44 45 43 55 59 58 52 50 48 44 44.3 days
DIO 16 17 14 14 17 18 16 15 16 16 17 16 17 19 17 20 21 20 19 17 17.1 days
DPO 38 40 37 36 34 34 36 29 30 29 36 35 32 36 38 45 44 44 49 49 49.2 days
Cash Conversion Cycle 25 19 28 32 39 28 22 26 27 27 25 27 28 37 38 33 28 26 19 12 12.3 days
Fixed Asset Turnover snapshot only 3.895
Operating Cycle snapshot only 61.5 days
Cash Velocity snapshot only 74.539
Capital Intensity snapshot only 1.345
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 1.2% 1.2% 72.0% 28.8% 20.6% 30.6% 37.7% 45.4% 41.2% 14.1% 1.5% 0.2% -0.2% -22.0% -18.8% -19.2% -12.7% 7.4% 17.1% 22.9% 22.85%
Net Income 1.8% 2.1% 2.7% 4.3% 40.8% -55.6% -78.6% -68.4% -5.5% -10.8% -17.1% -17.0% 49.8% 1.1% 1.1% 1.1% 1.4% -1.8% -2.0% -3.9% -3.86%
EPS 1.3% 1.5% 2.5% 4.3% 43.6% -54.9% -78.2% -68.2% -5.6% -10.9% -17.5% -17.0% 50.4% 1.1% 1.1% 1.1% 1.4% -1.8% -2.0% -3.9% -3.88%
FCF -48.4% -53.6% -35.3% -84.1% -4.0% -1.2% -43.8% 10.0% -53.5% 9.2% 20.2% 6.7% 6.5% 64.7% 4.2% 39.1% -7.0% -7.0% -30.1% -57.8% -57.75%
EBITDA 40.0% 9.9% 20.4% 2.3% 51.2% 2.6% -11.3% 0.3% -85.7% -1.4% -1.4% -1.4% 2.6% 4.1% 3.8% 3.9% 1.2% -22.9% -20.4% -52.5% -52.47%
Op. Income 4.0% 2.3% 2.4% 1.0% 23.3% -15.6% -36.9% -37.3% -2.5% -4.1% -4.5% -4.6% 85.4% 1.4% 1.4% 1.5% 6.1% -15.6% -12.7% -1.0% -1.04%
OCF Growth snapshot only 5.60%
Asset Growth snapshot only -0.23%
Equity Growth snapshot only -13.16%
Debt Growth snapshot only 5.89%
Shares Change snapshot only -0.69%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 1.2% 1.0% 79.9% 69.9% 68.0% 77.7% 74.4% 66.0% 56.2% 47.5% 34.0% 23.3% 19.3% 5.1% 4.3% 5.6% 7.2% -1.5% -1.2% -0.2% -0.17%
Revenue 5Y — — — — — — — 1.2% 80.8% 64.9% 52.1% 48.2% 46.2% 37.9% 34.3% 29.9% 27.1% 21.9% 18.0% 13.3% 13.25%
EPS 3Y 1.3% 1.7% 1.6% 1.5% 1.8% — — — — — — — — -16.7% -24.3% -16.2% -5.4% — — — —
EPS 5Y — — — — — — — 70.4% — — — — — — — — — — — — —
Net Income 3Y 2.8% 3.4% 3.2% 3.7% 4.2% — — — — — — — — -16.7% -24.9% -16.2% -5.4% — — — —
Net Income 5Y — — — — — — — 1.3% — — — — — — — — — — — — —
EBITDA 3Y — — 2.6% 2.5% 1.6% 1.1% 1.9% 1.2% 1.1% — — — -7.6% 4.9% -0.8% 3.1% 5.2% -4.7% -4.3% -19.7% -19.67%
EBITDA 5Y — — — — — — — — — — — — 56.0% 58.1% 93.6% 61.5% 1.4% — 75.4% 11.7% 11.72%
Gross Profit 3Y 91.8% 76.4% 15.2% — — 61.3% 78.7% 73.3% 62.5% 62.5% 35.3% 23.7% 43.0% -15.3% 5.3% — — -24.0% -14.5% -2.9% -2.93%
Gross Profit 5Y — — — — — — — 1.2% 79.2% 69.1% 50.3% 47.4% 46.1% 10.1% 4.2% 0.6% 22.3% 3.3% 10.7% 10.9% 10.88%
Op. Income 3Y — — — — — — 2.0% 90.2% — — — — — 5.3% -3.3% 1.0% 4.6% 5.4% 7.7% — —
Op. Income 5Y — — — — — — — — — — — — — — 1.1% 62.5% 47.8% 26.3% 21.9% — —
FCF 3Y 36.4% 12.9% 8.8% -29.9% 8.2% — -0.5% -44.1% -38.7% -2.8% -24.1% 10.3% 49.6% 48.2% 51.6% 1.3% 48.0% — 63.0% 65.1% 65.12%
FCF 5Y — — — — — — — 21.3% 2.5% 23.3% -2.7% 23.8% 34.6% 43.3% 43.6% 13.3% 9.9% 7.1% 9.5% -4.7% -4.66%
OCF 3Y 91.8% 68.9% 64.0% 60.6% 76.7% 83.6% 86.9% 43.6% 37.5% 34.9% 27.1% 29.2% 34.4% 25.3% 22.0% 22.8% 14.6% 17.2% 10.3% 10.7% 10.65%
OCF 5Y — — — — — — — 1.1% 67.6% 53.1% 39.6% 47.4% 51.5% 55.1% 53.7% 30.6% 28.5% 25.2% 25.9% 20.2% 20.22%
Assets 3Y 1.7% 1.7% 1.7% 1.7% 1.7% 1.1% 99.9% 91.6% 45.0% 35.5% -0.1% -1.3% -4.9% -5.1% -5.2% -5.8% -5.8% -6.1% -5.7% -5.9% -5.86%
Assets 5Y — — — — — — — 83.2% 79.6% 77.7% 77.6% 77.5% 77.1% 52.4% 46.3% 42.5% 23.1% 18.9% -0.4% -1.5% -1.53%
Equity 3Y 1.0% 1.0% 1.0% 1.1% 1.1% — — 5.4% 56.9% 60.2% -6.5% -7.7% -8.7% -8.7% -9.5% -9.4% -9.1% -11.0% -11.3% -14.2% -14.18%
Book Value 3Y 21.9% 24.4% 24.7% 11.2% 11.5% — — 3.5% 18.0% 26.8% -10.6% -7.6% -7.8% -8.7% -8.7% -9.4% -9.0% -11.2% -11.3% -14.2% -14.16%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.91 0.90 0.93 0.95 0.96 0.98 1.00 0.95 0.96 0.96 0.96 0.97 0.96 0.71 0.67 0.66 0.73 0.48 0.49 0.46 0.461
Earnings Stability 0.06 0.11 0.24 0.25 0.33 0.17 0.19 0.25 0.23 0.26 0.25 0.30 0.31 0.04 0.05 0.07 0.02 0.01 0.02 0.10 0.102
Margin Stability 0.78 0.80 0.55 0.08 0.00 0.80 0.55 0.25 0.12 0.80 0.61 0.26 0.13 0.60 0.44 0.03 0.14 0.52 0.60 0.60 0.600
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
Earn. Growth Consistency 0.50 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 0 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.200
Earnings Smoothness — — — — 0.66 0.23 0.00 0.00 — — — — — — — — — — — — —
ROE Trend 0.13 — — 2.06 0.12 0.20 0.00 -0.00 -0.29 -0.52 -0.53 -0.51 -0.04 0.27 0.28 0.27 0.24 0.16 0.16 0.04 0.040
Gross Margin Trend -0.06 -0.05 -0.12 -0.21 -0.18 0.01 0.08 0.11 0.14 0.07 0.05 0.11 0.13 -0.11 -0.13 -0.13 -0.06 -0.06 0.01 0.05 0.049
FCF Margin Trend -0.09 -0.08 -0.05 -0.11 -0.07 -0.10 -0.05 -0.03 -0.02 0.03 -0.01 0.04 0.05 0.07 0.09 0.06 0.04 0.01 0.00 -0.04 -0.039
Sustainable Growth Rate 5.5% 12.9% 10.3% 6.8% 4.6% 3.3% 2.0% 2.0% — — — — — 6.0% 5.6% 5.2% 5.1% — — — —
Internal Growth Rate 2.0% 4.6% 4.3% 2.8% 1.9% 1.3% 0.8% 0.8% — — — — — 2.1% 1.9% 1.9% 1.8% — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 3.34 1.77 1.60 2.18 3.98 5.39 10.35 9.96 -0.99 -0.71 -0.56 -0.72 -2.55 5.99 6.89 6.85 7.10 -8.26 -7.34 -2.53 -2.533
FCF/OCF 0.30 0.26 0.24 0.07 0.17 -0.05 0.10 0.05 0.07 0.30 0.14 0.33 0.42 0.44 0.47 0.42 0.37 0.36 0.32 0.17 0.167
FCF/Net Income snapshot only -0.424
OCF/EBITDA snapshot only 1.935
CapEx/Revenue 8.2% 8.9% 10.6% 12.5% 13.5% 13.2% 12.6% 12.6% 12.0% 10.0% 10.4% 10.3% 9.7% 11.6% 11.9% 12.2% 12.5% 13.5% 13.3% 15.0% 15.05%
CapEx/Depreciation snapshot only 1.093
Accruals Ratio -0.05 -0.03 -0.03 -0.03 -0.05 -0.06 -0.08 -0.07 -0.17 -0.24 -0.22 -0.25 -0.17 -0.10 -0.11 -0.11 -0.11 -0.15 -0.15 -0.19 -0.187
Sloan Accruals snapshot only -0.090
Cash Flow Adequacy snapshot only 1.201
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — — — — 0.0% 0.0% 0.0% 0.0% — — — —
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 65.7% 0.0% 0.0% 2.5% 14.8% 20.2% 53.7% 45.9% — — — — — 0.3% 0.3% 0.9% 0.9% — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 1.4% 0.0% 0.0% 0.1% 0.5% 0.5% 1.4% 1.2% 0.8% 3.0% 1.3% 1.5% 1.3% 0.0% 0.0% 0.1% 0.1% 0.1% 0.0% 0.0% 0.00%
Net Buyback Yield -7.2% -8.4% 0.0% 0.1% 0.5% 0.5% 1.4% 1.2% 0.6% 2.9% 1.2% 1.4% 1.3% -0.0% -0.1% -0.0% -0.0% -0.0% -0.0% -0.1% -0.11%
Total Shareholder Return -7.2% -8.4% 0.0% 0.1% 0.5% 0.5% 1.4% 1.2% 0.6% 2.9% 1.2% 1.4% 1.3% -0.0% -0.1% -0.0% -0.0% -0.0% -0.0% -0.1% -0.11%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.83 0.82 0.83 0.78 0.74 0.71 0.67 0.70 0.95 0.94 0.95 0.95 1.04 0.66 0.68 0.54 0.52 4.81 2.72 0.93 0.932
Interest Burden (EBT/EBIT) 0.49 0.67 0.71 0.64 0.55 0.47 0.36 0.33 1.40 1.22 1.22 1.22 2.72 0.52 0.51 0.56 0.58 -0.17 -0.41 1.73 1.730
EBIT Margin 0.09 0.13 0.15 0.12 0.10 0.07 0.06 0.06 -0.10 -0.18 -0.19 -0.18 -0.02 0.10 0.09 0.10 0.09 0.03 0.02 -0.04 -0.044
Asset Turnover 0.57 0.64 0.48 0.45 0.44 0.57 0.61 0.62 0.66 0.70 0.66 0.67 0.71 0.59 0.59 0.59 0.64 0.64 0.69 0.74 0.742
Equity Multiplier 2.76 2.92 2.49 2.46 2.52 2.49 2.45 2.41 2.56 2.70 2.70 2.65 2.83 2.97 2.95 2.88 2.83 2.85 2.88 2.93 2.931
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $0.48 $1.15 $1.46 $1.00 $0.69 $0.52 $0.32 $0.32 $-3.16 $-5.10 $-5.24 $-5.08 $-1.57 $0.66 $0.63 $0.59 $0.58 $-0.54 $-0.60 $-1.69 $-1.69
Book Value/Share $14.18 $15.12 $15.28 $15.57 $15.66 $16.04 $15.88 $16.01 $12.83 $10.97 $11.00 $10.92 $11.11 $11.51 $11.63 $11.58 $11.78 $11.21 $11.10 $10.13 $10.18
Tangible Book/Share $-11.27 $-12.12 $-11.50 $-11.42 $-11.22 $-11.61 $-11.31 $-11.11 $-10.70 $-10.50 $-10.39 $-9.89 $-9.55 $-8.86 $-8.66 $-8.45 $-8.21 $-8.18 $-8.40 $-7.52 $-7.52
Revenue/Share $13.69 $16.67 $16.73 $16.28 $16.83 $22.15 $23.46 $23.80 $24.22 $25.48 $24.37 $23.89 $23.91 $19.36 $19.51 $19.16 $20.77 $20.96 $22.67 $23.70 $22.11
FCF/Share $0.49 $0.53 $0.57 $0.14 $0.48 $-0.13 $0.33 $0.16 $0.23 $1.08 $0.40 $1.22 $1.68 $1.73 $2.04 $1.69 $1.55 $1.62 $1.41 $0.72 $0.72
OCF/Share $1.60 $2.02 $2.34 $2.17 $2.75 $2.79 $3.29 $3.16 $3.13 $3.61 $2.93 $3.68 $4.00 $3.97 $4.36 $4.03 $4.15 $4.44 $4.42 $4.28 $4.28
Cash/Share $2.40 $1.10 $0.86 $0.87 $0.80 $0.34 $0.75 $0.33 $0.42 $0.58 $0.60 $0.51 $0.73 $0.80 $0.40 $0.50 $0.59 $0.78 $0.35 $0.32 $0.32
EBITDA/Share $2.63 $3.99 $4.55 $4.23 $4.06 $4.16 $4.11 $4.27 $0.59 $-1.52 $-1.66 $-1.62 $2.13 $4.60 $4.56 $4.63 $4.74 $3.57 $3.60 $2.21 $2.21
Debt/Share $16.97 $17.38 $17.00 $17.08 $16.92 $17.36 $17.24 $16.98 $17.06 $17.25 $17.64 $16.39 $15.96 $15.60 $15.60 $14.23 $13.88 $14.05 $14.74 $15.17 $15.17
Net Debt/Share $14.57 $16.29 $16.14 $16.21 $16.11 $17.02 $16.49 $16.65 $16.64 $16.67 $17.05 $15.87 $15.22 $14.80 $15.21 $13.73 $13.29 $13.27 $14.38 $14.85 $14.85
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 0.695
Altman Z-Prime snapshot only -0.172
Piotroski F-Score 7 7 6 6 7 7 7 6 4 5 5 5 5 6 5 5 6 5 5 6 6
Beneish M-Score -2.49 -1.33 -3.36 -3.68 -2.81 -2.65 -3.87 -2.83 -3.40 -3.76 -5.07 -3.15 -3.08 -3.64 -3.30 -3.21 -3.94 -2.70 -4.22 -4.20 -4.203
Ohlson O-Score snapshot only -5.924
Net-Net WC snapshot only $-15.85
EVA snapshot only $-348435260.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only CCC
Credit Score 27.40 39.77 38.05 33.92 34.78 36.93 30.30 29.60 21.07 30.24 29.12 28.75 22.76 39.22 39.31 36.88 38.46 27.44 22.32 19.58 19.585
Credit Grade snapshot only 17
Credit Trend snapshot only -17.290
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 10
Sector Credit Rank snapshot only 9

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms